JPRN-jRCTs062190030已完成2 期
Randomized controlled trial of the development of new treatment for depression using neurofeedback based on neuroimaging biomarkers.
Okamoto Yasumasa0 个研究点目标入组 2 人开始时间: 2020年1月30日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 2
研究概览
简要总结
Recruiting did not proceed and the research was discontinued.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 80age old（—）
- 性别
- All
入选标准
- •(1)Patients aged 20 years and over,under 80 years (outpatient or hospitalized patient).
- •(2)Subjects are diagnosed with major depressive disorder according to DSM-TR or DSM-5.
- •(3)Currently subjects meet diagnostic criteria for major depressive episodes (according to M.I.N.I.).
- •(4)In the latest major depressive episodes,with treatment-resistant(HRSD score is 14 points or more with sufficient doses of antidepressants for 4 weeks or more) or with treatment low tolerance(impossible to take in adequate amount antidepressants by serious side effects).
- •(5)Signed informed consent by oneself.
排除标准
- •(1)Incapability to understand the purpose of the study.
- •(2)Impossible to examine on the ground of serious illness.
- •(3)It`s difficult for subjects below to get an MRI.
- •- With an implanted cardiac pacemaker.
- •- With a brain vascular clip.
- •- Users of a nerve electrical stimulator.
- •- With an implanted pump in one's body.
- •- With a piece of metal in one's body.
- •- With tattoos (including permanent makeup etc).
- •- Pregnancy or possibly pregnant.
- •- MRI claustrophobia.
- •(4)Those participating in other intervention studies.
研究者
相似试验
已完成
1 期
The development of novel treatment using transcranial magnetic stimulation for patients with mood disordersJPRN-jRCTs062180023Okamoto Yasumasa3
已完成
不适用
Randomized controlled trial of the influence on mucosal regulatory T cells and fecal butyric acid by administration of Clostridium butyricum and resistant starch for pediatric ulcerative colitislcerative colitisJPRN-UMIN000023885juntendo University
已完成
不适用
ART-PterostilbeneInfertilityJPRN-jRCTs031210153Kawamura Kazuhiro
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190098Takimoto Rishu40